Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 12.515% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: Nc1nc2nn(-c3ccccc3)nc2c(=O)[nH]1
b: N/C(Cc1cccc2ccccc12)=N\OC(=O)Cc1cccs1
c: CCN1C(=O)CC(C(=O)NCCc2ccc(S(N)(=O)=O)cc2)SC1=Nc1ccc(OC)cc1
Answer: a. Nc1nc2nn(-c3ccccc3)nc2c(=O)[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nc1nc2nn(-c3ccccc3)nc2c(=O)[nH]1
Nc1nc2nn(-c3ccccc3)nc2c(=O)[nH]1
5-amino-2-phenyl-6H-triazolo[4,5-d]pyrimidin-7-one